Regulation of atherosclerotic plaque inflammation

Abstract

The immune reactions that regulate atherosclerotic plaque inflammation involve chemokines, lipid mediators and costimulatory molecules. Chemokines are a family of chemotactic cytokines that mediate immune cell recruitment and control cell homeostasis and activation of different immune cell types and subsets. Chemokine production and activation of chemokine receptors form a positive feedback mechanism to recruit monocytes, neutrophils and lymphocytes into the atherosclerotic plaque. In addition, chemokine signalling affects immune cell mobilization from the bone marrow. Targeting several of the chemokines and/or chemokine receptors reduces experimental atherosclerosis, whereas specific chemokine pathways appear to be involved in plaque regression. Leukotrienes are lipid mediators that are formed locally in atherosclerotic lesions from arachidonic acid. Leukotrienes mediate immune cell recruitment and activation within the plaque as well as smooth muscle cell proliferation and endothelial dysfunction. Antileukotrienes decrease experimental atherosclerosis, and recent observational data suggest beneficial clinical effects of leukotriene receptor antagonism in cardiovascular disease prevention. By contrast, other lipid mediators, such as lipoxins and metabolites of omega-3 fatty acids, have been associated with the resolution of inflammation. Costimulatory molecules play a central role in finetuning immunological reactions and mediate crosstalk between innate and adaptive immunity in atherosclerosis. Targeting these interactions is a promising approach for the treatment of atherosclerosis, but immunological side effects are still a concern. In summary, targeting chemokines, leukotriene receptors and costimulatory molecules could represent potential therapeutic strategies to control atherosclerotic plaque inflammation.

Chitotriosidase: A New Inflammatory Marker in Diabetic Complications

“…Inflammation and endothelial dysfunction initiate the course of atherosclerosis, from the earliest steps of monocyte recruitment to the complicated phase of plaque rupture [21]. Atherosclerotic lesion-related thrombosis is the major cause of myocardial infarction and stroke, which together constitute the principal cause of mortality worldwide.…”

Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with 18F positron emission tomography

“…This continues throughout the natural history of the plaque with attraction and accumulation of monocytes at the site of plaques continuing throughout and in a manner proportional to plaque size (21). Monocytes and macrophages are the most abundant leukocyte involved in atherogenesis but others, including neutrophils, T and B cells, also contribute to promoting inflammation both directly and by co-stimulatory interaction between themselves (20,22). Oxidized subendocardial LDL contributes to the formation of foam cells from macrophages, and to the inflammatory milieu of atherosclerosis.…”

Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes

“…14,15 An important costimulatory dyad in cardiovascular disease is CD40 and its ligand CD40L (CD154).…”